Three compounds dominate the published research: BPC-157 (a gastric pentadecapeptide with unusual protease resistance), TB-500 (a synthetic fragment of thymosin beta-4), and GHK-Cu (a copper-binding tripeptide with broad ECM-modulating effects)
Daily subcutaneous injection is the standard protocol in supervised clinical settings, typically dosed once daily or split into twice daily depending on the indication and the providers assessment
The Sikiric groups foundational research, published in major pharmacology journals and indexed at the NIH National Library of Medicine, demonstrates direct gastroprotective and anti-inflammatory action in the gut mucosa
Furthermore, NCT03810872 explores the utility of intermittent afatinib in patients with EGFR, HER2, or HER3 mutations to mitigate resistance via on-off EGFR/HER blockade
We can help evaluate your health needs and determine the best course of action, potentially including vitamin B12 injections
Appearance: Blue to purplish-blue lyophilized powder